77 related articles for article (PubMed ID: 3388967)
1. [Neurobiological aspects of alcoholism].
Anokhina IP
Vestn Akad Med Nauk SSSR; 1988; (3):21-7. PubMed ID: 3388967
[No Abstract] [Full Text] [Related]
2. Drug therapy for alcohol dependence.
Swift RM
N Engl J Med; 1999 May; 340(19):1482-90. PubMed ID: 10320388
[No Abstract] [Full Text] [Related]
3. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Lideman RR; Zlobina GP; Mukhin AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
[No Abstract] [Full Text] [Related]
4. Medications acting on the dopaminergic system in the treatment of alcoholic patients.
Swift R
Curr Pharm Des; 2010; 16(19):2136-40. PubMed ID: 20482513
[TBL] [Abstract][Full Text] [Related]
5. [Central dopaminergic mechanisms and the effect of ethyl alcohol].
Kostowski W; Puciłowski O
Psychiatr Pol; 1989; 23(3):200-8. PubMed ID: 2696998
[No Abstract] [Full Text] [Related]
6. Dopamine and alcoholism: neurobiological basis of ethanol abuse.
Tupala E; Tiihonen J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1221-47. PubMed ID: 15588749
[TBL] [Abstract][Full Text] [Related]
7. Detection of multiple receptors for dopamine.
Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
[No Abstract] [Full Text] [Related]
8. Striatal dopamine receptors and adenylyl cyclase activity in a rat model of alcohol addiction: effects of ethanol and lisuride treatment.
May T; Wolf U; Wolffgramm J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1195-203. PubMed ID: 8531081
[TBL] [Abstract][Full Text] [Related]
9. [Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
Havemann U
Arzneimittelforschung; 1981; Suppl 27():18-22. PubMed ID: 6118158
[No Abstract] [Full Text] [Related]
10. Maturational aspects of the dopaminergic system: ontogenesis of high affinity dopamine binding to neural membrane fragments of the rat brain.
Karakiulakis G; Paradelis AG; Papaioannidou PG; Thomas PJ
Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):685-94. PubMed ID: 6672486
[TBL] [Abstract][Full Text] [Related]
11. [The dopamine system of the brain and alcoholism].
Anokhina IP
Vestn Ross Akad Med Nauk; 1992; (7):7-11. PubMed ID: 1281714
[No Abstract] [Full Text] [Related]
12. Drugs for relapse prevention of alcoholism: ten years of progress.
Spanagel R; Kiefer F
Trends Pharmacol Sci; 2008 Mar; 29(3):109-15. PubMed ID: 18262663
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in alcoholism:pharmacological treatment.
Gorelick DA
Recent Dev Alcohol; 1993; 11():413-27. PubMed ID: 8234933
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for the existence of multiple receptors for dopamine in the central nervous system.
Iversen LL; Quik M; Emson PC; Dowling JE; Watling KJ
Adv Biochem Psychopharmacol; 1980; 21():193-202. PubMed ID: 6103646
[No Abstract] [Full Text] [Related]
15. [The effect of medikhronal on the biogenic amine level in the brain structures and blood of animals with alcohol dependence].
Kharchenko NK
Fiziol Zh (1994); 1999; 45(4):111-9. PubMed ID: 10474811
[TBL] [Abstract][Full Text] [Related]
16. [The pathogenetic treatment of alcoholism].
Seleznev AG
Lik Sprava; 1997; (6):143-5. PubMed ID: 9589961
[TBL] [Abstract][Full Text] [Related]
17. [Neuropharmacology of apomorphine (review of the literature)].
Zharkovskiĭ AM; Allikmets LKh
Farmakol Toksikol; 1981; 44(2):226-32. PubMed ID: 7023969
[No Abstract] [Full Text] [Related]
18. [Biological basis of the screening of drugs for differentiated pharmacotherapy of alcoholism].
Val'dman AV; Maĭskiĭ AI; Kampov-Polevoĭ AB; Treskov VG; Drozdov ES
Vestn Akad Med Nauk SSSR; 1988; (3):28-32. PubMed ID: 3388968
[No Abstract] [Full Text] [Related]
19. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles.
Breese GR; Knapp DJ; Criswell HE; Moy SS; Papadeas ST; Blake BL
Brain Res Brain Res Rev; 2005 Feb; 48(1):57-73. PubMed ID: 15708628
[TBL] [Abstract][Full Text] [Related]
20. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
Gackenheimer SL; Schaus JM; Gehlert DR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
